Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.
Acetylcholine
Alpha-synuclein
Lewy body dementia
Mitochondria
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
09 07 2020
09 07 2020
Historique:
received:
30
06
2020
accepted:
01
07
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
1
6
2021
Statut:
epublish
Résumé
Neurons of the nucleus basalis of Meynert (nbM) are vulnerable to Lewy body formation and neuronal loss, which is thought to underlie cognitive dysfunction in Lewy body dementia (LBD). There is continued debate about whether Lewy bodies exert a neurodegenerative effect by affecting mitochondria, or whether they represent a protective mechanism. Therefore, the present study sought to determine whether the nbM is subject to mitochondrial dysfunctional in LBD and the association of Lewy body formation with such changes. Post-mortem nbM tissue was stained for Complex I or IV and quantitated relative to porin with immunofluorescence using confocal microscopy of individual cells from LBD (303 neurons, 8 cases), control (362 neurons, 8 cases) and asymptomatic incidental LBD (iLBD) cases (99 neurons, 2 cases). Additionally, α-synuclein, tau and amyloid-β pathology were analysed using quantitative immunohistochemistry, and respiratory chain markers were compared in cells with Lewy bodies (N = 134) and unaffected cells (N = 272). The expression of Complex I normalised to mitochondrial mass was significantly lower in LBD compared to control and iLBD cases and this was unrelated to local neuropathological burdens but trended toward a relationship with neuronal loss. Furthermore, Complex I expression was higher in cells with Lewy bodies compared to adjacent cells without α-synuclein aggregates. These findings suggest that Complex I deficits in the nbM occur in symptomatic LBD cases and may relate to neuronal loss, but that contrary to the view that Lewy body formation underlies neuronal dysfunction and damage in LBD, Lewy bodies are associated with higher Complex I expression than neurons without Lewy bodies. One could speculate that Lewy bodies may provide a mechanism to encapsulate damaged mitochondria and/or α-synuclein oligomers, thus protecting neurons from their cytotoxic effects.
Identifiants
pubmed: 32646480
doi: 10.1186/s40478-020-00985-8
pii: 10.1186/s40478-020-00985-8
pmc: PMC7346628
doi:
Substances chimiques
Electron Transport Complex I
EC 7.1.1.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103Subventions
Organisme : Wellcome Trust
ID : 203105/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0900652
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0502157
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400074
Pays : United Kingdom
Organisme : Alzheimer's Research UK
ID : ARUK-RF-2018C-005
Pays : International
Références
J Comp Neurol. 1988 Sep 8;275(2):216-40
pubmed: 3220975
J Chem Neuroanat. 2016 Oct;76(Pt B):73-81
pubmed: 26777894
Cell Metab. 2015 Jun 2;21(6):805-21
pubmed: 26039447
Neuropathol Appl Neurobiol. 2020 Apr;46(3):264-278
pubmed: 31454423
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10481-10486
pubmed: 30249646
Nat Commun. 2018 Jun 12;9(1):2293
pubmed: 29895861
Cell Stress. 2017 Oct;1(1):11-36
pubmed: 30542671
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Neurology. 2007 Jul 24;69(4):356-9
pubmed: 17646627
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982
pubmed: 32075919
Handb Clin Neurol. 2016;138:153-8
pubmed: 27637957
Drug Discov Today. 2019 Dec;24(12):2307-2314
pubmed: 31499186
Neurosci Bull. 2019 Apr;35(2):295-300
pubmed: 30729454
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):842-9
pubmed: 3404192
Arch Biochem Biophys. 2018 Aug 1;651:1-12
pubmed: 29702063
J Comp Neurol. 1983 Feb 20;214(2):170-97
pubmed: 6841683
Ann Neurol. 2005 Jan;57(1):82-91
pubmed: 15562510
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
J Vis Exp. 2019 Jun 2;(148):
pubmed: 31205308
J Neurochem. 2019 Sep;150(5):626-636
pubmed: 31265130
J Alzheimers Dis. 2017;57(3):787-795
pubmed: 28304294
Neuropathol Appl Neurobiol. 2016 Feb;42(2):180-93
pubmed: 25786813
Neurology. 1999 Oct 12;53(6):1284-91
pubmed: 10522886
Science. 1982 Mar 5;215(4537):1237-9
pubmed: 7058341
Neurology. 1997 Aug;49(2):610-3
pubmed: 9270609
Acta Neuropathol Commun. 2019 Mar 14;7(1):41
pubmed: 30871620
Cell Tissue Res. 2018 Jul;373(1):149-160
pubmed: 29869713
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Acta Neuropathol. 2018 Mar;135(3):409-425
pubmed: 29270838
Am J Geriatr Psychiatry. 2017 Jun;25(6):595-604
pubmed: 28190674
Neurology. 1999 Dec 10;53(9):2003-9
pubmed: 10599772
J Neurochem. 1990 Mar;54(3):823-7
pubmed: 2154550
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
Nat Neurosci. 2019 Jul;22(7):1099-1109
pubmed: 31235907
J Geriatr Psychiatry Neurol. 2002 Winter;15(4):182-7
pubmed: 12489913
J Neurochem. 2019 Sep;150(5):612-625
pubmed: 31055836
Brain Pathol. 2017 Jan;27(1):3-12
pubmed: 26667592
Arch Neurol. 2012 Mar;69(3):385-93
pubmed: 22410447
Mol Neurodegener. 2019 Jan 21;14(1):5
pubmed: 30665447
Acta Neuropathol. 2015 Apr;129(4):527-40
pubmed: 25633602
Cells. 2019 Jun 09;8(6):
pubmed: 31181865
ACS Chem Neurosci. 2019 Jun 19;10(6):2683-2691
pubmed: 31117342
Alzheimer Dis Assoc Disord. 1993 Summer;7(2):69-79
pubmed: 8347330
Cell Chem Biol. 2018 Nov 15;25(11):1389-1402.e9
pubmed: 30197194
Acta Neuropathol. 2000 Sep;100(3):285-90
pubmed: 10965798
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879